Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Patterson

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenström's macroglobulinemiaBryan T Ciccarelli, Christopher J Patterson, Zachary R Hunter, et al.
Blood Advances|September 21, 2020
Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenström's macroglobulinemiaCristina Jiménez, Lian Xu, Nickolas Tsakmaklis, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström MacroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
British Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
Cancer Epidemiology|November 22, 2011
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary studyRohit P Ojha, Christina A Hanzis, Zachary R Hunter, et al.
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Hemasphere|July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical TrialsJorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenström's macroglobulinemiaBryan T Ciccarelli, Christopher J Patterson, Zachary R Hunter, et al.
Blood Advances|September 21, 2020
Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenström's macroglobulinemiaCristina Jiménez, Lian Xu, Nickolas Tsakmaklis, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström MacroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
British Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
Cancer Epidemiology|November 22, 2011
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary studyRohit P Ojha, Christina A Hanzis, Zachary R Hunter, et al.
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Hemasphere|July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical TrialsJorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Pageof 11